The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with <i>Clostridium difficile</i> Infection.

The final experimental days of A+Vanc.group (days 10–20) had oscillating proportions of Staphylococcus (significantly decreased on days 12–16 and increased on day 20) and a decreasing trend of Enterobacter/Klebsiella resembling the original microbiome composition (Figure 3 ).

also in 47,180 other papers